1. Home
  2. RGP vs MCRB Comparison

RGP vs MCRB Comparison

Compare RGP & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$4.27

Market Cap

151.8M

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$13.46

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
MCRB
Founded
1996
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.8M
139.7M
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
RGP
MCRB
Price
$4.27
$13.46
Analyst Decision
Buy
Hold
Analyst Count
2
3
Target Price
$6.00
$14.33
AVG Volume (30 Days)
517.2K
53.8K
Earning Date
01-07-2026
03-12-2026
Dividend Yield
6.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.62
Revenue
$506,739,000.00
$351,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.49
N/A
P/E Ratio
N/A
$21.64
Revenue Growth
N/A
N/A
52 Week Low
$4.13
$6.53
52 Week High
$8.43
$29.98

Technical Indicators

Market Signals
Indicator
RGP
MCRB
Relative Strength Index (RSI) 38.80 35.54
Support Level $4.19 $12.99
Resistance Level $4.75 $16.12
Average True Range (ATR) 0.21 0.93
MACD 0.00 -0.14
Stochastic Oscillator 14.41 13.44

Price Performance

Historical Comparison
RGP
MCRB

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: